Christel Rousseaux
Lille, 59000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
A metabolic constraint in de novo NAD+ synthesis drives mucosal inflammation in IBD.
Journal: Journal of Crohn's & colitis
Published: June 01, 2026
A Synbiotic Combining Chitin-Glucan and Lactobacillus acidophilus NCFM Induces a Colonic Molecular Signature Soothing Intestinal Pain and Inflammation in an Animal Model of IBS.
Journal: International journal of molecular sciences
Published: September 02, 2024
Chitin-glucan improves important pathophysiological features of irritable bowel syndrome.
Journal: World journal of gastroenterology
Published: January 25, 2024
Efficacy and tolerability of chitin-glucan combined with simethicone (GASTRAP® DIRECT) in irritable bowel syndrome: A prospective, open-label, multicenter study.
Journal: World journal of gastrointestinal pharmacology and therapeutics
Published: January 25, 2024
Changes in HLA-B27 Transgenic Rat Fecal Microbiota Following Tofacitinib Treatment and Ileocecal Resection Surgery: Implications for Crohn's Disease Management.
Journal: International journal of molecular sciences
Published: January 12, 2024
An oral cholera vaccine in the prevention and/or treatment of inflammatory bowel disease.
Journal: PloS one
Published: April 12, 2023
Safety and Efficacy of an AIEC-targeted Bacteriophage Cocktail in a Mice Colitis Model.
Journal: Journal of Crohn's & colitis
Published: August 23, 2022
GED-0507 is a novel potential antifibrotic treatment option for pulmonary fibrosis.
Journal: Cellular & molecular immunology
Published: February 19, 2020
Peroxisome proliferator-activated receptor gamma (PPARγ) regulates lactase expression and activity in the gut.
Journal: EMBO molecular medicine
Published: September 27, 2017
Last Updated: 09/26/2026